Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Cannabis Supply Chain Risk Grows As Global Conflict Raises Costs
MJBizDaily reports that fuel cost spikes and global supply chain disruption tied to the U.S. led war on Iran are creating new pressure for cannabis operators. The bigger lesson is that freight costs, packaging delays, and weak vendor redundancy can turn geopolitical risk into a direct margin problem.
Vireo Fluent Deal Shows Florida Cannabis Consolidation Is Not Slowing Down
Vireo Growth’s planned acquisition of Fluent shows that Florida cannabis consolidation is still moving. The bigger lesson for operators is that capital access, debt pressure, and scale can decide who keeps control in a limited license market.
Why Cannabis Insurance Premiums Are Rising
Cannabis insurance premiums are rising as carriers price off real claims tied to fires, spoilage, crime, inflation, and litigation. Operators that present cleaner risk profiles and stronger controls will be in a better position when the market gets tougher.
Cannabis Stocks Jumped Then Slid After a Narrow Federal Move
Cannabis stocks jumped on the federal reclassification headline, then slid when investors realized the immediate relief is narrower than many first thought. The move helps FDA approved and state licensed medical cannabis first, while adult use operators still face much of the same federal friction.
GLP 1 Boom Is Changing Edible Cannabis Advice
GLP 1 drugs are changing how dispensaries think about edibles. As digestion slows, lower dose products and clearer wait time guidance are becoming smarter retail moves, not just cautious ones.
Youth Cannabis Study Raises Policy Pressure
A major UC San Diego study found that youth who began using cannabis showed slower gains over time in memory, attention, and processing speed compared with non users. The bigger lesson is not hype or panic. It is that stronger youth risk evidence can quickly reshape public health messaging and policy pressure.
Colorado Springs Adult Use Hits a Year One Test
Colorado Springs just finished its first year of legal adult use cannabis sales, and the market has already produced a real fiscal proof point. The bigger lesson is that a controlled rollout backed by visible public revenue can turn cannabis from a political fight into a harder to ignore local business reality.
Long Island Cannabis Is Entering the Hard Part
Long Island’s cannabis market is shifting from rollout mode to execution mode. The real challenge now is not just getting open. It is standing out, surviving local friction, and staying funded long enough to become profitable.
Aurora Buys Safari Flower for EU GMP Growth
Aurora Cannabis bought Safari Flower to expand EU GMP capacity and serve higher margin medical markets such as Germany, Australia, Poland, and the UK. The bigger lesson is that real cannabis growth is getting more selective and more compliance driven.
4/20 Cannabis Retail Strategy Is Becoming a Demand Window
Retailers are rethinking 4 20 as a one day discount rush. New data suggests the real money is moving into the days before April 20, which is why smarter operators are stretching promos, building experiences, and protecting margin instead of chasing one loud day.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.